{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:05:15Z","timestamp":1760551515063},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,22]]},"DOI":"10.7759\/cureus.16566","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T16:49:25Z","timestamp":1626972565000},"source":"Crossref","is-referenced-by-count":2,"title":["In-Hospital Outcomes of Inflammatory Bowel Diseases in Patients With Diabetes Mellitus: A Propensity Score Matching Analysis"],"prefix":"10.7759","author":[{"given":"Ese","family":"Uwagbale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omolara G","family":"Adeniran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olayemi A","family":"Adeniran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifeanyichukwu","family":"Onukogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Agbroko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niket","family":"Sonpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000160772.78951.61","article-title":"The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology","volume":"11","author":"Hatoum OA","year":"2005","unstructured":"Hatoum OA, Binion DG. The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis. 2005, 11:304-13. 10.1097\/01.mib.0000160772.78951.61","journal-title":"Inflamm Bowel Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2007.06.005","article-title":"Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey","volume":"1","author":"Ghosh S","year":"2007","unstructured":"Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007, 1:10-20. 10.1016\/j.crohns.2007.06.005","journal-title":"J Crohns Colitis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20388","article-title":"Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality","volume":"14","author":"Vidal A","year":"2008","unstructured":"Vidal A, G\u00f3mez-Gil E, Sans M, Portella MJ, Salamero M, Piqu\u00e9 JM, Pan\u00e9s J. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis. 2008, 14:977-83. 10.1002\/ibd.20388","journal-title":"Inflamm Bowel Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab S","year":"2020","unstructured":"Alatab S, Sepanlou SG, Ikuta K, et al.. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020, 5:17-30. 10.1016\/S2468-1253(19)30333-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4110\/in.2017.17.1.25","article-title":"Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies","volume":"17","author":"Kim DH","year":"2017","unstructured":"Kim DH, Cheon JH. Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw. 2017, 17:25-40. 10.4110\/in.2017.17.1.25","journal-title":"Immune Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303661","article-title":"Geographical variability and environmental risk factors in inflammatory bowel disease","volume":"62","author":"Ng SC","year":"2013","unstructured":"Ng SC, Bernstein CN, Vatn MH, et al.. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013, 62:630-49. 10.1136\/gutjnl-2012-303661","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06818-x","article-title":"Inflammatory bowel disease does not impact mortality but increases length of hospitalization in patients with acute myocardial infarction","volume":"[Epub ahead of print]","author":"Sinh P","year":"2021","unstructured":"Sinh P, Tabibian JH, Biyani PS, Mehta K, Mansoor E, Loftus EV Jr, Dave M. Inflammatory bowel disease does not impact mortality but increases length of hospitalization in patients with acute myocardial infarction. Dig Dis Sci. 2021, [Epub ahead of print]:10.1007\/s10620-020-06818-x","journal-title":"Dig Dis Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss KS","year":"2006","unstructured":"Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006, 12:4819-31. 10.3748\/wjg.v12.i30.4819","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-018-0188-9","article-title":"Inflammatory bowel disease in the baby to baby boomer: pediatric and elderly onset of IBD","volume":"16","author":"Afzali A","year":"2018","unstructured":"Afzali A, Katz S. Inflammatory bowel disease in the baby to baby boomer: pediatric and elderly onset of IBD. Curr Treat Options Gastroenterol. 2018, 16:289-305. 10.1007\/s11938-018-0188-9","journal-title":"Curr Treat Options Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06439-4","article-title":"Comorbid diabetes in inflammatory bowel disease predicts adverse disease-related outcomes and infectious complications","volume":"66","author":"Kumar A","year":"2021","unstructured":"Kumar A, Teslova T, Taub E, Miller JD, Lukin DJ. Comorbid diabetes in inflammatory bowel disease predicts adverse disease-related outcomes and infectious complications. Dig Dis Sci. 2021, 66:2005-13. 10.1007\/s10620-020-06439-4","journal-title":"Dig Dis Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i6.850","article-title":"Diabetes mellitus: the epidemic of the century","volume":"6","author":"Kharroubi AT","year":"2015","unstructured":"Kharroubi AT, Darwish HM. Diabetes mellitus: the epidemic of the century. World J Diabetes. 2015, 6:850-67. 10.4239\/wjd.v6.i6.850","journal-title":"World J Diabetes"},{"key":"ref12","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Estimates of diabetes and its burden in the United States. (2020). Accessed. May 4, 2021: https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7150\/jca.14264","article-title":"Effect of ulcerative colitis on incidence of colorectal cancer: results from the Nationwide Population-Based Cohort Study (2003-2013)","volume":"7","author":"Choi JK","year":"2016","unstructured":"Choi JK, Kim DW, Shin SY, Park EC, Kang JG. Effect of ulcerative colitis on incidence of colorectal cancer: results from the Nationwide Population-Based Cohort Study (2003-2013). J Cancer. 2016, 7:681-6. 10.7150\/jca.14264","journal-title":"J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000380763","article-title":"Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center: a retrospective cohort study","volume":"91","author":"Fitzmorris PS","year":"2015","unstructured":"Fitzmorris PS, Colantonio LD, Torrazza Perez E, Smith I, Kakati DD, Malik TA. Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center: a retrospective cohort study. Digestion. 2015, 91:257-62. 10.1159\/000380763","journal-title":"Digestion"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz305","article-title":"Disease characteristics and severity in patients with inflammatory bowel disease with coexistent diabetes mellitus","volume":"26","author":"Din H","year":"2020","unstructured":"Din H, Anderson AJ, Ramos Rivers C, et al.. Disease characteristics and severity in patients with inflammatory bowel disease with coexistent diabetes mellitus. Inflamm Bowel Dis. 2020, 26:1436-42. 10.1093\/ibd\/izz305","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2011.11.006","article-title":"Inflammation and type 2 diabetes","volume":"38","author":"Calle MC","year":"2012","unstructured":"Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012, 38:183-91. 10.1016\/j.diabet.2011.11.006","journal-title":"Diabetes Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbacli.2015.11.002","article-title":"Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: the links","volume":"5","author":"Jurjus A","year":"2016","unstructured":"Jurjus A, Eid A, Al Kattar S, et al.. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: the links. BBA Clin. 2016, 5:16-24. 10.1016\/j.bbacli.2015.11.002","journal-title":"BBA Clin"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida A","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018, 11:1-10. 10.1007\/s12328-017-0813-5","journal-title":"Clin J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02247","article-title":"The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease","volume":"9","author":"Zuo T","year":"2018","unstructured":"Zuo T, Ng SC. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol. 2018, 9:2247. 10.3389\/fmicb.2018.02247","journal-title":"Front Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0642-1","article-title":"Targeting inflammation through a physical active lifestyle and pharmaceuticals for the treatment of type 2 diabetes","volume":"15","author":"Knudsen SH","year":"2015","unstructured":"Knudsen SH, Pedersen BK. Targeting inflammation through a physical active lifestyle and pharmaceuticals for the treatment of type 2 diabetes. Curr Diab Rep. 2015, 15:82. 10.1007\/s11892-015-0642-1","journal-title":"Curr Diab Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2015.101","article-title":"Exercise and type 2 diabetes: focus on metabolism and inflammation","volume":"94","author":"Karstoft K","year":"2016","unstructured":"Karstoft K, Pedersen BK. Exercise and type 2 diabetes: focus on metabolism and inflammation. Immunol Cell Biol. 2016, 94:146-50. 10.1038\/icb.2015.101","journal-title":"Immunol Cell Biol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.94253","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16 Suppl 1","author":"Casqueiro J","year":"2012","unstructured":"Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012, 16 Suppl 1:S27-36. 10.4103\/2230-8210.94253","journal-title":"Indian J Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-121723","article-title":"Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia","volume":"112","author":"Stegenga ME","year":"2008","unstructured":"Stegenga ME, van der Crabben SN, Bl\u00fcmer RM, et al.. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008, 112:82-9. 10.1182\/blood-2007-11-121723","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001049","article-title":"Risk for overall infection with anti-TNF and anti-integrin agents used in IBD: a systematic review and meta-analysis","volume":"23","author":"Shah ED","year":"2017","unstructured":"Shah ED, Farida JP, Siegel CA, Chong K, Melmed GY. Risk for overall infection with anti-TNF and anti-integrin agents used in IBD: a systematic review and meta-analysis. Inflamm Bowel Dis. 2017, 23:570-7. 10.1097\/MIB.0000000000001049","journal-title":"Inflamm Bowel Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aet290","article-title":"Demystifying propensity scores","volume":"112","author":"Okoli GN","year":"2014","unstructured":"Okoli GN, Sanders RD, Myles P. Demystifying propensity scores. Br J Anaesth. 2014, 112:13-5. 10.1093\/bja\/aet290","journal-title":"Br J Anaesth"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.crvasa.2013.04.001","article-title":"Why to use propensity score in observational studies? Case study based on data from the Czech clinical database AHEAD 2006-09 [Article in Czech]","volume":"55","author":"Littnerova S","year":"2013","unstructured":"Littnerova S, Jarkovsky J, Parenica J, Pavlik T, Spinar J, Dusek L. Why to use propensity score in observational studies? Case study based on data from the Czech clinical database AHEAD 2006-09 [Article in Czech]. Cor et Vasa. 2013, 55: e383-90. 10.1016\/j.crvasa.2013.04.001","journal-title":"Cor et Vasa"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61335-in-hospital-outcomes-of-inflammatory-bowel-diseases-in-patients-with-diabetes-mellitus-a-propensity-score-matching-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:53Z","timestamp":1707506873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61335-in-hospital-outcomes-of-inflammatory-bowel-diseases-in-patients-with-diabetes-mellitus-a-propensity-score-matching-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.16566","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}